FDA Sets Outcomes Benchmarks For Actual Use Trials
This article was originally published in The Tan Sheet
Executive Summary
FDA is providing OTC switch application sponsors with pre-defined benchmarks for actual use trials, Center for Drug Evaluation and Research executive Andrea Leonard-Segal says